-
Study aim
-
The aim of the present study is to investigate the effect of DASH-based weight loss diet on serum Lipopolysaccharide level and meta-inflammation status among patients with non-alcoholic fatty liver disease.
-
Design
-
Randomized double blind clinical trial with two arm parallel groups
-
Settings and conduct
-
Volunteer patients in the Tabriz city whose disease is diagnosed by a newly diagnosed specialist will be included in the study and met the inclusion criteria and will be randomly assigned to the intervention and control groups.
-
Participants/Inclusion and exclusion criteria
-
44 patients with grade 1 and 2 NAFLD aged 20-50 years and BMI 30-40 kg / m2 will be included in the study.Alcohol consumption, pregnancy, breastfeeding , menopause , being an athlete , having a weight loss diet 3 months before the study , the use of lowering blood sugar , lipid , blood pressure drugs , antibiotics and corticosteroids , suffering from metabolic disease , cardiovascular , renal , kidney stone , liver disease , thyroid disease , autoimmune and cancer are among the exclusion criteria.
-
Intervention groups
-
Patients in the intervention group will receive a weight loss diet based on the DASH diet.
Patients in the control group will receive the usual weight loss diet.
-
Main outcome variables
-
Nutritional status (anthropometric indices , and calorie and macronutrients intake),Serum levels of liver enzymes (ALT, AST) and ultrasound findings ,Serum levels of lipopolysaccharides(LPS) , Meta-inflammation status ( MCP-1, TLR-4 )